使用综合结构和基于体的方法探索结构-活性关系:基于酸的HDAC抑制剂和细胞毒剂
Ekta Shirbhate1, Jaiprakash Pandey1, Vijay Kumar Patel1
1Guru Ghasidas University, Department of Pharmacy, Bilaspur, India.
Turkish journal of pharmaceutical sciences
|August 22, 2023
概括
这项研究开发了基因组脱乙酶 (HDAC) 抑制剂的定量结构-活性关系 (QSAR) 模型. 计算分析发现39分子是抑制HDAC活性和开发新抗癌药物的有希望的候选者.
科学领域:
- 药用化学 医学化学
- 计算化学的计算化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 基斯脱乙酶 (HDAC) 抑制剂在癌症治疗中至关重要.
- 了解结构-活性关系是设计强效抗癌剂的关键.
- 现有的QSAR模型需要对HDAC抑制剂进行验证和增强.
研究的目的:
- 为HDAC抑制剂建立验证的定量结构-活性关系 (QSAR) 模型.
- 为了将分子特性与抗癌活性相关联.
- 通过计算方法识别新的HDAC抑制剂候选者.
主要方法:
- 从以前的研究中编制数据集.
- 使用XP滑翔的分子对接.
- 使用PHASE.pharmacophore和3D QSAR建模进行3D QSAR建模.
- 部分最小方程分析用于QSAR验证.
主要成果:
- 分子39表现出优越的对接得分和有利的结合相互作用.
- 3D QSAR分析给出了假设AADRR.139.9.2的高R2 (0.9877) 和Q2 (0.7142) 值.
- 低标准偏差 (0.1049) 表明一个强大的QSAR模型.
结论:
- 分子39是抑制HDAC的强大而有效的候选者.
- 计算方法,包括QSAR和对接,对于发现新药候选药物非常有价值.
- 这项研究支持在制药和医疗保健领域开发新的治疗剂.
相关概念视频
Structure-Activity Relationships and Drug Design
768
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
768
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
606
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
606
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.1K
Local Anesthetics: Chemistry and Structure-Activity Relationship
4.4K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
4.4K
EDTA: Chemistry and Properties
2.0K
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
2.0K


